FlexShares快捷通道可变收益基金 RAVI 深 沪
等待开盘 08-06 09:30:00 美东时间
75.36
+0.003
+0.00%
华盛通- 最 高75.369
- 今 开75.34
- 成交量 9.58万股
- 最 低 75.34
- 昨 收 75.357
- 总市值 12.82亿
- 52周最高 76.0811
- 市盈率 静 --
- 换手率 0.56%
- 52周最低 71.7263
- 委 比 0.00%
- 总股本 1701.00万
- 历史最高 76.0811
- 量 比 2.03
- 振 幅 0.04%
- 历史最低 51.8996
- 每 手 1
- 风险率 1.04%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Gravita India Schedules Investor Meeting with ASK Investment Managers
Gravita India Limited ( ($IN:GRAVITA) ) has shared an announcement. Gravita Ind...
08-05 01:13
GRAVITY Co Q1 EPS $2.15, Sales $93.23M Up From $88.92M YoY
GRAVITY Co (NASDAQ:GRVY) reported quarterly earnings of $2.15 per share. This is a 25.09 percent decrease over earnings of $2.87 per share from the same period last year. The company reported $93.23 million in sales
05-09 18:35
AMGEN REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS
THOUSAND OAKS, Calif., May 1, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced financial results for the first quarter of 2025. "Demand for our products was strong globally in the fi...
05-02 04:01
Gravita India Announces Director Change Following Term Completion
Gravita India Limited ( ($IN:GRAVITA) ) has shared an update. Gravita India Lim...
03-24 09:12
Gravita India Engages Investors with Transparency
Gravita India Limited ( ($IN:GRAVITA) ) has shared an update. Gravita India Lim...
03-19 20:53
GRAVITY Reports Q4 Tentative Consolidated Revenue Of KRW 130B, Representing 1.3% Increase Q/Q And 10.7% Decrease YoY
Tentative tentative consolidated operating profit is KRW 16 billion. The preliminary fourth quarter of 2024 result is mainly attributed by increased revenues from THE RAGNAROK launched in Southeast Asia on October 31,
02-14 19:18
Gravita India Limited Schedules Investor Meeting in Jaipur
Gravita India Limited ( ($IN:GRAVITA) ) has shared an announcement. Gravita Ind...
02-04 18:27
Earnings Scheduled For November 12, 2024
Companies Reporting Before The Bell • UP Fintech Holding (NASDAQ:TIGR) is likel...
2024-11-12 16:32
强生(JNJ.US)单抗疗法公布3期积极数据 实现显著的临床缓解和内镜应答
日前，强生(JNJ.US)公布其白细胞介素-23（IL-23）靶向抗体Tremfya（guselkumab）在GRAVITI临床3期研究的积极结果。
2024-10-30 14:01
GRAVITY shares are trading lower. The company reported Q2 financial results.
GRAVITY shares are trading lower. The company reported Q2 financial results.
2024-08-10 00:58
